» Articles » PMID: 33572939

Functional Role of B Cells in Atherosclerosis

Overview
Journal Cells
Publisher MDPI
Date 2021 Feb 12
PMID 33572939
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is a lipid-driven inflammatory disease of blood vessels, and both innate and adaptive immune responses are involved in its development. The impact of B cells on atherosclerosis has been demonstrated in numerous studies and B cells have been found in close proximity to atherosclerotic plaques in humans and mice. B cells exert both atheroprotective and pro-atherogenic functions, which have been associated with their B cell subset attribution. While B1 cells and marginal zone B cells are considered to protect against atherosclerosis, follicular B cells and innate response activator B cells have been shown to promote atherosclerosis. In this review, we shed light on the role of B cells from a different, functional perspective and focus on the three major B cell functions: antibody production, antigen presentation/T cell interaction, and the release of cytokines. All of these functions have the potential to affect atherosclerosis by multiple ways and are dependent on the cellular milieu and the activation status of the B cell. Moreover, we discuss B cell receptor signaling and the mechanism of B cell activation under atherosclerosis-prone conditions. By summarizing current knowledge of B cells in and beyond atherosclerosis, we are pointing out open questions and enabling new perspectives.

Citing Articles

Causal relationship between immune cells and risk of myocardial infarction: evidence from a Mendelian randomization study.

Cao W, Wang K, Wang J, Chen Y, Gong H, Xiao L Front Cardiovasc Med. 2024; 11:1416112.

PMID: 39257847 PMC: 11384581. DOI: 10.3389/fcvm.2024.1416112.


The relationship of redox signaling with the risk for atherosclerosis.

Lei S, Liu C, Zheng T, Fu W, Huang M Front Pharmacol. 2024; 15:1430293.

PMID: 39148537 PMC: 11324460. DOI: 10.3389/fphar.2024.1430293.


B cells and atherosclerosis: A HIV perspective.

Obare L, Bonami R, Doran A, Wanjalla C J Cell Physiol. 2024; 239(6):e31270.

PMID: 38651687 PMC: 11209796. DOI: 10.1002/jcp.31270.


Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.

Xia Y, Gao D, Wang X, Liu B, Shan X, Sun Y Front Immunol. 2024; 15:1331609.

PMID: 38558816 PMC: 10978666. DOI: 10.3389/fimmu.2024.1331609.


A mendelian randomization study investigates the causal relationship between immune cell phenotypes and cerebral aneurysm.

Shi X, Wang T, Teng D, Hou S, Lin N Front Genet. 2024; 15:1333855.

PMID: 38313677 PMC: 10834707. DOI: 10.3389/fgene.2024.1333855.


References
1.
Chang M, Bergmark C, Laurila A, Horkko S, Han K, Friedman P . Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A. 1999; 96(11):6353-8. PMC: 26885. DOI: 10.1073/pnas.96.11.6353. View

2.
Albany C, Trevelin S, Giganti G, Lombardi G, Scotta C . Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis. Front Immunol. 2019; 10:2795. PMC: 6894511. DOI: 10.3389/fimmu.2019.02795. View

3.
Moon B, Takaki S, Miyake K, Takatsu K . The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol. 2004; 172(10):6020-9. DOI: 10.4049/jimmunol.172.10.6020. View

4.
Dal Porto J, Gauld S, Merrell K, Mills D, Pugh-Bernard A, Cambier J . B cell antigen receptor signaling 101. Mol Immunol. 2004; 41(6-7):599-613. DOI: 10.1016/j.molimm.2004.04.008. View

5.
Jones K, Savulescu A, Brombacher F, Hadebe S . Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?. Front Immunol. 2020; 11:595535. PMC: 7662119. DOI: 10.3389/fimmu.2020.595535. View